logo

Zentalis Pharmaceuticals, Llc (ZNTL)



Trade ZNTL now with
  Date
  Headline
5/10/2022 4:46:25 PM Wedbush Is Cutting Zentalis Pharmaceuticals, LLC (ZNTL) FY22 Estimate To -4.54 From -4.38
5/10/2022 4:46:12 PM Wedbush Is Cutting Zentalis Pharmaceuticals, LLC (ZNTL) Q4 22 Estimate To -1.12 From -1.09
5/10/2022 4:45:59 PM Wedbush Is Cutting Zentalis Pharmaceuticals, LLC (ZNTL) Q3 22 Estimate To -1.10 From -1.07
5/10/2022 4:45:46 PM Wedbush Is Raising Zentalis Pharmaceuticals, LLC (ZNTL) Q2 22 Estimate To -1.08 From -1.13
5/10/2022 4:45:23 PM Wedbush Reiterates Zentalis Pharmaceuticals, LLC (ZNTL) At Outperform With $51 Down From $71 Price Target
4/11/2022 4:35:03 PM Wedbush Reiterates Zentalis Pharmaceuticals, LLC (ZNTL) At Outperform With $71 Price Target
3/22/2022 7:34:54 AM Zentalis Pharma Doses 1st Patient In Potentially Registrational Phase 1/2 Study Of ZN-d5 For R/R Light Chain Amyloidosis
11/17/2021 7:30:59 AM Zentalis Pharma Announces Fast Track Designation Granted By FDA To ZN-c3 For Uterine Serous Carcinoma
11/11/2021 6:38:44 AM Wedbush Reiterates Zentalis Pharmaceuticals, LLC (ZNTL) At Outperform With $89 Price Target
4/12/2021 7:17:01 AM Zentalis Announces Clinical Collaboration Agreement With GlaxoSmithKline